Which hedge funds own IMVT? IMMUNOVANT INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
8 of the hedge funds tracked by WhaleCreep disclosed a position in IMVT (IMMUNOVANT INC) in their Q2 2026 13F filings, worth $402.1m in total. The largest holder by portfolio weight is Farallon Capital Management at 1.3% of its book. 3 managers opened a new position this quarter: D. E. Shaw & Co, Tudor Investment, Millennium Management.
8tracked managers holding
3opened this quarter
0exited this quarter
Which hedge funds hold IMVT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Farallon Capital Management | Q2 2026 | 1.3% | $223.7m | 5,805,000 | 275% | added |
| Woodline Partners | Q2 2026 | 0.2% | $76.1m | 1,975,869 | 0% | held |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $28.0m | 726,800 | 278% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $47.8m | 1,240,654 | – | new |
| Tudor Investment | Q2 2026 | 0.0% | $2.2m | 57,145 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $12.7m | 328,678 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $5.5m | 142,488 | -14% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $6.2m | 160,123 | 11% | added |
How has hedge fund ownership of IMVT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $402.1m |
| Q1 2026 | 5 | $100.0m |
| Q4 2025 | 4 | $102.0m |
| Q3 2025 | 4 | $81.3m |
| Q2 2025 | 4 | $81.4m |
| Q1 2025 | 6 | $68.2m |
| Q4 2024 | 5 | $56.9m |
| Q3 2024 | 6 | $119.9m |
| Q2 2024 | 8 | $156.7m |
| Q1 2024 | 8 | $188.5m |
| Q4 2023 | 9 | $188.9m |
| Q3 2023 | 5 | $112.8m |
| Q2 2023 | 5 | $69.4m |
| Q1 2023 | 4 | $27.0m |
| Q4 2022 | 3 | $28.3m |
| Q3 2022 | 3 | $22.8m |
Counts every tracked manager that disclosed IMVT in that quarter's filing, including managers that have since stopped filing.